-transparent.png){kind=logo}
Lisuride hydrogen maleate, a semisynthetic ergoline and potent central dopamine and serotonin agonist, was tested in 10 patients with moderate to marked Parkinson disease whose response to levodopa had diminished. In the group of 10 patients, there was a significant reduction (p less than or equal to 0.05) in bradykinesia, gait disorder, and total Parkinson disease disability score when levodopa was replaced with lisuride. The mean dose of lisuride was 3.6 mg per day. Among the 10 patients, 5 were better on lisuride than on levodopa, and 4 continue on lisuride 1 year later. A decline in efficacy was noted in all four after a mean of 45 months. Adverse effects necessitating discontinuing the drug were mental changes in three patients and nausea in one patient. Lisuride, when used alone, has definite antiparkinsonian activity and is a promising new drug.
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
January 1985,
Medicina,
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
January 1990,
Advances in neurology,
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
January 1983,
Annals of neurology,
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
August 1987,
Italian journal of neurological sciences,
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
January 2000,
The Cochrane database of systematic reviews,
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
April 1987,
Wiener medizinische Wochenschrift (1946),
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
September 2000,
Archives of neurology,
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
September 2000,
Archives of neurology,
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
December 2011,
Nature reviews. Neurology,
A Lieberman, and
M Goldstein, and
A Neophytides, and
M Kupersmith, and
M Leibowitz, and
N Zasorin, and
R Walker, and
D Kleinberg
January 2000,
The Cochrane database of systematic reviews,
